Return to homepagePandemic Pact

COVID19AM: Clinical Study (COVIC-19) - Efficacy of Early Transfusion of Convalescent Plasma with Very High Antibody Concentrations in Vulnerable Patients with COVID-19 as a Model for Early Therapy Options in Pandemic Situations with New Pathogens

  • Funded by Federal Ministry of Research, Technology and Space (BMFTR)
  • Total publications:0 publications

Grant number: 03LW0108

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2021
    2023

  • Known Financial Commitments (USD)

    $2,968,663.04

  • Funder

    Federal Ministry of Research, Technology and Space (BMFTR)

  • Research Location

    Germany

  • Lead Research Institution

    Deutsches Rotes Kreuz Blutspendedienst Baden-Württemberg - Hessen gemeinnützige Gesellschaft mit beschränkter Haftung

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Clinical trial (unspecified trial phase)

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Vulnerable populations unspecified

  • Occupations of Interest

    Unspecified

Abstract

N/A